Multiple de-rating not finished — a 26× multiple on a ~10% grower still has room to compress
One-line thesis. A high-quality, wide-moat professional-information franchise (legal, tax, Reuters) with a fortress balance sheet and 4.4% dividend — but a mid-single-digit grower that just lost ~57% of its value in a violent de-rating from a bubble multiple; the business is fine, the price is catching a falling knife, and with zero expert coverage we Watch rather than buy.
◆ Synthos call — HoldTRI is a solid business largely reflected at ~$98 — fine to keep, no reason to chase; it gets interesting again below ~$83.
Downside Risk (lower = safer)
5/10 · Moderate
Fortress balance sheet (net-debt/EBITDA 0.66×) & 0.18 beta — but a −57% 12-mo crash shows the de-rating risk in a 26× ~10%-grower.
~4–6% revenue growth, decelerating post-2021 peak, mature TAM at $39B cap — a compounder, not an exponential.
⚖ Reverse-DCF cross-checkMarket-implied growth ≈ 13%/yrTo justify today’s $89, earnings would have to compound roughly 13% a year for 10 years (9% discount rate). Analysts forecast ~16%/yr, so the market is pricing in LESS than what the Street expects.What do the 5 tiers mean? (Core · Tactical · Watch · Hold · Avoid)
Buy — CoreOwn it as a foundation — start or add now, size it for years, let dips be gifts.
Buy — TacticalGood price + confirmed trend + a defined exit — buy the setup, not a marriage.
WatchWe want the business, just not at this price/setup — act only when the listed trigger hits.
HoldFine to keep if you own it — no reason to buy more; new money does better elsewhere.
AvoidDon't own it — the problem is the business or the expectations, so a cheaper price won't fix it.
In plain English
Thomson Reuters sells the essential software and information that lawyers, accountants, and corporations rely on every day — legal research (Westlaw), tax and accounting tools, and the Reuters news wire. Customers pay every year and rarely switch, so the revenue is steady and the profits are fat (it keeps about 20 cents of every sales dollar as profit).
The problem is the stock, not the business. A year ago the market paid a sky-high price for it — over $200 a share, near 50× earnings — and this year that optimism collapsed. The stock has fallen about 57% to $89. That's not because the company fell apart; sales still grew. It's because the price was too high and is resetting toward something reasonable.
Our verdict is Watch — the company is solid, but it grows slowly and the price is still adjusting downward, so there's no rush. We have zero expert analysts covering this name in our knowledge base, so this call rests only on the numbers.
Here's what our three scores mean in everyday terms:
Downside Risk 5/10 (middle). The company has very little debt and its stock is normally calm — but it just proved it can drop like a rock when the price is too high.
Growth Quality 5/10 (solid but slow). A durable, profitable business, but it grows only a few percent a year — reliable, not exciting.
Exponential Potential 2/10 (low). Do not expect this to multiply your money. It's a mature, slow grower in a mature market.
The one big worry: the price may still have further to fall. A calm 26× earnings for a company growing ~10% a year is not obviously cheap yet.
Solid = price · dashed = 50-day average · dotted = 200-day average · amber = 52-week high/low. Price above both averages is an uptrend.
Bollinger Bands 20-day average ± 2 standard deviations
The shaded band widens when the stock gets more volatile. Riding the upper edge = strong momentum (sometimes stretched); the lower edge = weak / potentially oversold.
Blue crossing above amber (bars flip green) = momentum turning up; below (bars red) = turning down. Bar height = the size of that gap.
Relative performance vs S&P 500 & its sector (XLI (sector)), set to 100 a year ago
Solid = TRI · dashed = S&P 500 · dotted = XLI (sector). A rising line means it is beating that benchmark — the sector line shows whether it is a leader or laggard within its own group.
Darker bars = actual results, brighter = analyst estimates. Taller bars to the right = expected growth.
Key stats an RIA wants
Price$89.21
Market cap$39B
P/E trailing4×
P/E FY26E / FY27E21× / 18×
EV / Sales5.4×
EV / EBITDA13.1×
Gross margin75.8%
Net margin19.9%
Dividend yield4.42%
Beta0.178
52-wk range$77 – $218
RSI(14)68
50 / 200-DMA$86 / $115
12-mo return+-56% (SPY +21%)
Street target$137 ($85–$183)
Analyst grades14 Buy · 10 Hold · 3 Sell
FMP ratingA-
Next earnings2026-08-05
What the experts actually said 0 traceable claims on TRI · showing the highest-conviction voices
Every claim reconciles to a real claim_id in the Synthos knowledge base — this is the evidence the verdict is built on, not vibes. Management (the company itself) is shown but half-weighted; one cautionary voice is included on purpose.
1. What it is
Thomson Reuters (NASDAQ: TRI) is a ~175-year-old (founded 1851) global professional-information and workflow-software company headquartered in Toronto and controlled by The Woodbridge Company (the founding Thomson family). It sells subscription content, tools and analytics into five divisions: Legal Professionals (Westlaw, Practical Law), Corporates (legal/tax/compliance tech), Tax & Accounting Professionals (research + workflow automation), Reuters News (the global wire), and Global Print (a declining legacy print business). Fiscal year ends December 31.
Revenue mix (from FMP segmentation):
By product/type (FY2025): "Electronic Software and Services" $6.99B — essentially the entire business is now recurring digital subscription revenue; the legacy Global Print line has shrunk to immateriality (it was ~$0.6B as recently as 2021 and is no longer separately broken out in FY25). This is the core quality attribute: sticky, recurring, high-renewal revenue embedded in customer workflows.
By geography: FMP's granular geographic split is stale (2017: Americas ~$7.0B, EMEA ~$3.0B, Asia-Pacific ~$1.3B — but that 2017 base includes the since-divested Financial & Risk / Refinitiv unit). Today the business is heavily US/Americas-weighted with meaningful EMEA and a smaller APAC tail. Treat the geo detail as directional only.
The strategic story management is telling is a "content-driven AI" pivot — embedding generative-AI assistants (e.g. CoCounsel) into Westlaw and the tax/accounting suites to defend and expand the subscription base. That is the swing factor for whether TRI re-accelerates or stays a mid-single-digit grower.
2. The expert thesis (traceability)
There is no expert coverage of TRI in the Synthos knowledge base.total_claims = 0, net_bullish_voices = 0 — no distilled analyst, podcast, or investor claims reconcile to this ticker. We therefore cite no claim_id values, because none exist.
Per house standard, this is stated plainly rather than papered over: the verdict below is entirely fundamentals- and quant-driven — built from FMP financials, analyst consensus estimates (labeled as estimates), the price/technical block, and Synthos's own scenario model. It carries Low conviction precisely because there is no independent expert breadth to corroborate it. A reader looking for a "smart-money agrees" signal will not find one here; the case stands or falls on the numbers.
3. Synthos scores & the Bull / Base / Bear cases
The one-glance judgment — three scores, 0–10, each anchored to real metrics (not probabilities we can't honestly calibrate):
Score
0–10
The read
Downside Risk(lower = safer)
5 · Moderate
Net-debt/EBITDA 0.66×, beta 0.18, 4.4% dividend and 76% gross margin make the business sturdy — but the stock just posted a −59% max drawdown, and 26× trailing on a ~10% grower means valuation risk is not exhausted.
Growth Quality
5 · Solid
Durable, sticky recurring revenue and strong margins (EBITDA margin ~41% TTM, ROE ~13%), but only ~4–6% revenue and ~10% EPS growth ahead — quality without much speed.
Exponential Potential
2 · Low
Growth is decelerating off the 2021 peak, the professional-information TAM is mature, and at a $39B cap there is no small-name room-to-run. This is a compounder, not a multibagger.
The three cases (our own scenario model — assumptions shown; each target is a ~12–18-month fair value). We deliberately do not attach probabilities: the base case is by definition the expected path, so a weighted blend would just restate it with false precision. Instead the cases bound the range, and the scores above summarize them.
Case
Key assumptions
Fair value
Bull
AI (CoCounsel) drives net-price and retention up; organic growth reaccelerates toward ~7–8%. FY27E EPS beats to ~$5.10 (vs $4.91 cons); the de-rating reverses to a ~24× quality multiple.
~$122 (+37%)
Base(our anchor)
Estimates roughly hit — FY27E EPS $4.91; a ~4–6% grower with a strong moat settles at a ~20× multiple as the crash stabilizes.
~$98 (+10%)
Bear
AI monetization disappoints / open-source legal AI compresses pricing; the de-rating overshoots. FY27E EPS misses to ~$4.50; multiple compresses to ~15×.
~$68 (−24%)
Synthos fair value = the base case, ~$98 (+10%), with the full $68–$122 span as the honest range. Our base sits well below the Street's $137.44 consensus — we read most street targets as stale, set before or during the crash and not yet marked to a 26× tape (the Street low of $85 is essentially at today's price). This is a tracked call — the Forecaster Scorecard grades it once it matures.
4. Exponential Potential
Synthos separates compounders (durable high returns on capital) from exponentials (accelerating, multi-baggers-from-here). TRI is a mature, decelerating compounder — the opposite of an exponential:
Forward growth: revenue CAGR FY25→FY28E ~7.0% ($7.48B → $9.17B); EPS CAGR ~18% off a depressed FY25 base ($3.40 → $5.65), flattering to ~10% on normalized earnings power. Mid-single-digit at the top line.
Acceleration (the 2nd derivative) is negative: organic revenue growth peaked around the post-Refinitiv-divestiture reset; the FY25→FY28E path (+5.4% → +7.6% → +8.2%) is a modest estimated reacceleration on AI hopes, but off a low base and nowhere near an inflection. There is no exponential curve here.
Room to run: the legal/tax/compliance professional-information TAM is large but mature and already well-penetrated by TRI's own franchises (Westlaw is the category standard). At a $39B cap the law of large numbers is not the constraint — the market's maturity is. A 3× from here would require a growth reacceleration the estimates simply do not show.
Reinvestment runway: capex is light (~8% of revenue), FCF is strong (~$2.05B FY25, ~5.4% FCF yield), and capital returns (dividend + buyback) — not reinvestment-for-growth — are where the cash goes. That is an income profile, not an exponential one.
Exponential Potential: Low (2/10). Own it, if at all, for durable ~10% earnings compounding plus a 4.4% dividend — never for a fast multibagger. Being honest about this is the whole point of the score.
Earnings: net income $1.502B FY25 (EPS $3.40) — down from FY24's $2.21B (EPS $4.89), largely on tax/discrete items (FY24 had a −$123M tax benefit inflating it); underlying earnings power is ~$4/share and rising. Q1'26 EPS $1.03.
Cash flow: operating CF ~$2.70B, capex ~−$0.65B, FCF ~$2.05B FY25 — comfortably funds the ~$1.05B dividend and ~$1.0B of buybacks. FCF yield ~5.4%.
Balance sheet: total debt $2.12B, net debt $1.61B, net-debt/EBITDA 0.66× — a genuine fortress; interest coverage ~12.6×. Heavy goodwill/intangibles ($12.7B, 71% of assets) from decades of acquisitions is the one asset-quality caveat.
6. Valuation — priced in or room?
The whole TRI story is a valuation reset. A year ago at ~$218 the stock traded near 50× earnings for a ~5% grower — a multiple that only made sense on an AI-supercycle narrative. That narrative deflated, and the stock fell to 26× trailing / EV-EBITDA 13.1× / EV-sales 5.4×. On forward estimates the multiple is 21× FY26E → 18× FY27E → 16× FY28E. Is that cheap? Not obviously: a ~4–6% revenue / ~10% EPS grower arguably deserves a high-teens multiple, so the de-rating may not be finished — which is the core reason for a Watch rather than a Buy. FMP's letter rating is A- (strong balance sheet and cash-flow scores, weak price-to-earnings/book scores — i.e. quality business, still-full price). Street targets (context): consensus $137.44, high $183, low $85 — we read the high/consensus as stale (pre-crash) and note the low ($85) is already at the market. Our $98 base gives credit to the moat and FCF but refuses to underwrite a re-rating the growth doesn't justify. Not a value buy yet; a wait-for-the-knife-to-land name.
7. Technicals (from the FMP tech block)
Trend:down. $89.21 sits below the 200-DMA ($115.05) though just above the 50-DMA ($86.03) after a small bounce. The 50 below the 200 is a death-cross posture — a broken chart.
Location:−59% off the 52-week high ($217.69), only +16.5% off the 52-week low ($76.55). Max drawdown from peak −59% — this is the defining fact of the chart.
Momentum: RSI(14) 68 — near-overbought on the recent bounce, not a sign of a clean base; MACD −0.31 (still mildly negative).
Relative strength (the tell): TRI −56.5% 12-mo vs SPY +20.6% and QQQ +30.3%; even 6-mo −33.9% vs SPY +8.4%. Catastrophic underperformance of both the market and the Nasdaq-100 it belongs to. The 3-mo (+1.3%) is only a faint stabilization.
Read: technicals do not confirm a bottom. A below-200-DMA name that has round-tripped a bubble, bouncing into an RSI-68 short-term overbought, is exactly the setup where patience (Watch) beats a hero entry. A base built above the 200-DMA would be the technical green light.
8. Moat & competitive position
TRI's moat is genuine and among the more durable in software-adjacent information: switching costs (Westlaw and the tax/accounting suites are embedded in professional workflows and cited in legal practice), proprietary content depth (175 years of legal, regulatory and news archives), and brand/regulatory trust (Reuters, Westlaw as category standards). Renewal rates are high and revenue is overwhelmingly recurring. The live debate is whether generative AI is a moat-widener or a moat-threat: TRI's own CoCounsel AI could deepen lock-in and lift pricing, or AI-native legal-research entrants and cheaper LLM-based tools could erode Westlaw's premium. The 2024 crash reflects the market swinging from the first view to fear of the second.
Peer set (FMP-supplied, market cap): the list is sector-bucket peers, not true business comps — Cintas $72.6B, Illinois Tool Works $78.5B, Emerson $77.9B, Johnson Controls $85.9B, Republic Services $66.9B, TransDigm $75.4B, Vertiv $115.4B, Quanta $100.3B, CSX $90.8B, Canadian Pacific KC $77.9B. TRI's real competitors are RELX, Wolters Kluwer, and Bloomberg/S&P in adjacent data — none in this FMP peer list. Treat the peer table as an industrials-index artifact, not a valuation anchor.
9. Management, capital allocation & guidance
Control structure: The Woodbridge Company (the Thomson family) is the controlling shareholder — a long-term, dividend-focused owner. This aligns management toward steady capital returns and disciplined M&A, but also means minority holders do not control the company.
Capital allocation: balanced and shareholder-friendly — ~$1.05B dividend (4.4% yield, a multi-decade grower), ~$1.0B buyback, and bolt-on acquisitions (~$0.6B FY25) into the AI/content strategy, all inside 0.66× net leverage. FCF comfortably covers it (dividend + capex coverage ~1.6×).
Insider activity: the FMP insider feed is stale (records date to 2007) and carries no signal for a current read; we flag the gap rather than infer from it.
Management guidance: no expert-KB guidance claims exist for TRI; the forward figures in this note are analyst consensus (FMP), explicitly labeled estimates, not company guidance we have independently verified.
10. Catalysts & what to watch
Next earnings: 2026-08-05 (Q2'26; Street EPS $0.96, revenue ~$1.88B). The key line: organic subscription growth and any AI (CoCounsel) monetization / net-price commentary — the swing factor for the whole thesis.
Organic growth trajectory: the Q1'26 +9.8% revenue reacceleration — does it hold, or fade back to ~5%?
AI product traction: CoCounsel attach rates, pricing uplift, and competitive response from AI-native legal/tax tools.
Multiple stabilization: whether the stock builds a base above the 200-DMA (~$115) or continues de-rating.
Capital returns: dividend growth and buyback pace as evidence management sees the stock as cheap.
Thesis tripwires (what would change the call): a clean base above the 200-DMA + evidence of AI-driven reacceleration would move this toward Buy — Tactical; conversely, organic growth slipping below ~3% or AI pricing pressure would push it toward Avoid.
11. Key risks
Valuation / continued de-rating (primary): 26× trailing on a ~10% grower — the reset may not be over; the stock has already shown it can halve.
AI disruption of the core: cheaper LLM-based legal/tax research could erode Westlaw's premium pricing — the existential debate behind the crash.
Growth maturity: a well-penetrated, mid-single-digit TAM offers little reacceleration runway absent AI upside.
Goodwill/intangibles heavy: 71% of assets are goodwill + intangibles from serial M&A; impairment risk if growth disappoints.
Controlled company: Woodbridge control limits minority-holder influence and takeover optionality.
No expert corroboration: zero KB breadth — no independent smart-money signal to lean on; conviction is structurally Low.
FX / geographic: a Canada-domiciled, US-revenue-weighted reporter carries currency translation noise.
12. Verdict, position sizing & monitoring
Watch. Thomson Reuters is a genuinely high-quality, wide-moat, fortress-balance-sheet business — but it is a mid-single-digit grower whose stock is mid-crash, down ~57% in twelve months from a bubble multiple, and still at 26× trailing with the de-rating possibly unfinished. The business does not justify a Buy at conviction, and the chart does not justify a hero entry. With zero expert coverage in the Synthos KB, there is no independent breadth to upgrade the call. The honest verdict is to watch for a base and for AI-driven reacceleration before committing.
Sizing: if owned for the 4.4% dividend and defensive quality, keep it a small satellite (≤1–2%) income/quality position — not a conviction holding. New money can wait for a confirmed base above the 200-DMA.
Monitoring: re-underwrite on the 2026-08-05 print (organic growth + AI commentary); a base above ~$115 with reaccelerating growth flips this toward Buy — Tactical. This verdict is logged as a tracked Synthos call as of 2026-07-03 at $89.21.
Single biggest risk: the multiple de-rating is not obviously finished — a calm 26× on a ~10% grower can still compress.
Provenance & disclosures
Traceability:0 KB claims, breadth 0 — no expert voices cover TRI in the Synthos knowledge base, so no claim_id values are cited (none exist). This note is fundamentals- and quant-driven; conviction is Low by design.
Data as-of: fundamentals 2026-03-31 (Q1'26) · estimates & prices 2026-07-02/03 · no expert claims. Forward figures are analyst consensus (FMP), labeled as estimates.
Data caveats: FMP geographic segmentation (2017) and insider feed (2007) are stale and used only directionally / flagged as no-signal; the FMP peer list is a sector-bucket artifact, not true business comps (real comps are RELX, Wolters Kluwer).
Not investment advice. Independent research, educational and informational only, never personalized. Hypothetical/forward figures are labeled; the only performance numbers Synthos will headline are the live, real-money Flagship's.
Version: 2026-07-03. Prior versions available via the deep-dive version dropdown ("based on the info at the time").